E2	Drug:T7 Name:T8
E4	Study:T9 Study-Of:E2
E1	Procedure:T1 Temporality:E3
E3	Eq-Comparison:T2 Temporal-Period:T3
E5	Drug:T4 
E6	Study:T5 Study-Of:E5
E7	Assertion:T6 Asserted:E5
E8	Observation:T10 Name:T11 Polarity:T12
E9	Procedure:T13 Temporality:E10
E10	Eq-Comparison:T14 Temporal-Period:T15
E11	Procedure:T16 Temporality:E12
E12	Eq-Comparison:T17 Temporal-Period:T18
E13	Drug:T19 Minimum-Count:E14
E14	Eq-Comparison:T20 Value:T21 Operator:T22
E15	Drug:T23 Name:T24
E16	Negation:T25 Negates:E15
E17	Eq-Comparison:T26 Temporal-Period:T27
E18	Drug:T28 Temporality:E17
E20	Study:T30 Study-Of:E22
E21	Other:T31 Is-Other:E20
E22	Drug:T32 
E23	Assertion:T33 Asserted:E22
T7	Drug 79 98	anetumab ravtansine
T8	Drug-Name 79 98	anetumab ravtansine
T9	Study 106 111	study
T1	Procedure 166 175	treatment
T2	Eq-Comparison 163 165	on
T3	Eq-Temporal-Period 163 165	on
T4	Drug 248 260	intervention
T5	Study 242 247	study
T6	Assertion 205 213	eligible
T10	Observation 359 379	serum pregnancy test
T11	Observation-Name 359 379	serum pregnancy test
T12	Polarity 350 358	positive
T13	Procedure 324 333	treatment
T14	Eq-Comparison 321 323	on
T15	Eq-Temporal-Period 321 323	on
T16	Procedure 393 402	treatment
T17	Eq-Comparison 390 392	on
T18	Eq-Temporal-Period 390 392	on
T19	Drug 454 465	medications
T20	Eq-Comparison 424 435	one or more
T21	Eq-Value 424 427	one
T22	Eq-Operator 428 435	or more
T23	Drug 584 603	anetumab ravtansine
T24	Drug-Name 584 603	anetumab ravtansine
T25	Negation 580 583	not
T26	Eq-Comparison 540 549	receiving
T27	Eq-Temporal-Period 540 549	receiving
T28	Drug 567 575	agent(s)
T30	Study 696 701	study
T31	Other 672 679	outside
T32	Drug 666 671	agent
T33	Assertion 633 640	able to
A1	Eq-Temporal-Period-Value T3 present
A2	Assertion-Type-Value E7 hypothetical
A3	Observation-Type-Value E8 lab
A4	Polarity-Value T12 positive
A5	Eq-Temporal-Period-Value T15 present
A6	Eq-Temporal-Period-Value T18 present
A7	Eq-Operator-Value T22 GTEQ
A8	Eq-Temporal-Period-Value T27 present
A9	Assertion-Type-Value E23 hypothetical
R1	If-Then Arg1:E1 Arg2:E5
R2	If-Then Arg1:E9 Arg2:E8
R3	If-Then Arg1:E11 Arg2:E13
R4	And Arg1:E18 Arg2:E16
R5	And Arg1:E18 Arg2:E23
